Dr. Reddy'S Laboratories (RDY) news

Dr Reddy's - USFDA inspection at API facility in UK classified 'Voluntary Action Indicated' and officially closed

Dr. Reddy's Labs ends distribution pact with Novartis India

Dr. Reddy's Laboratories has entered into an exclusive sales and distribution agreement with Novartis India Ltd (NIL) for select products, including the Voveran range, Calcium range, and Methergine . Under the arrangement, Dr. Reddy's will assume exclusive rights to promote and distribute these…

Novartis India - to re-buy exclusivity and market access for products after DRL agreement termination

Novartis India has announced plans to re-establish exclusivity and market access for certain products following the termination of its sales and distribution agreement with Dr. Reddy’s Laboratories (DRL). The agreement, which involved key brands such as Voveran, the Calcium range, and Methergine,…

Novartis India - approves termination of distribution agreement with Dr. Reddy’s Laboratories

Novartis India Ltd (NIL) has announced the termination of its distribution agreement with Dr. Reddy’s Laboratories, which was initially signed to enhance the reach of several established medicines, including the Voveran range , the Calcium range, and Methergine. The agreement, which aimed to…

Fresenius SE - announces FDA approval of rituximab biosimilar for U.S. market

Fresenius Kabi has received U.S. Food and Drug Administration (FDA) approval for a rituximab biosimilar, developed and submitted by Dr. Reddy’s Laboratories under a commercialization agreement . The biosimilar, which is a version of Roche’s Rituxan (rituximab), is indicated for the treatment of…